REPL - Replimune Announces Favorable Outcome of FDA 's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced M
REPL - Replimune Announces Favorable Outcome of FDA 's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma - Click For Release
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.